Showing results (1-10 of 183) with videos related to
Sort By:
Pageof 19
Urology Case Reports|October 26, 2020
CT-PLANNED transperineal prostate BIOPSY IN patients without a rectumGregory S Merrick, Brian Kurko, Whitney Scholl, et al.American Journal of Clinical Oncology|June 6, 2021
The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer PatientsGregory S Merrick, Robert Galbreath, Ryan Fiano, et al.BJUI Compass|April 27, 2022
The impact of age on prostate cancer progression and quality of life in active surveillance patientsGregory S Merrick, Gabe Rohmann, Robert Galbreath, et al.Urology|December 20, 2005
Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancerMark A Moyad, Gregory S Merrick, Wayne M Butler, et al.Journal of Contemporary Brachytherapy|January 28, 2016
Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohortsGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.Journal of Contemporary Brachytherapy|September 28, 2017
Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSAGregory S Merrick, Robert W Galbreath, Wayne M Butler, et al.American Journal of Clinical Oncology|December 4, 2004
Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA < 20 ng/mLGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.Brachytherapy|April 6, 2004
Biochemical outcome for hormone-naïve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiationGregory S Merrick, Wayne M Butler, Jonathan H Lief, et al.Brachytherapy|November 4, 2015
Is supplemental external beam radiation therapy essential to maximize brachytherapy outcomes in patients with unfavorable intermediate-risk disease?Gregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.American Journal of Clinical Oncology|October 15, 2016
Impact of Androgen Deprivation Therapy on Overall Mortality in Prostate Brachytherapy Patients With Low Pretreatment Testosterone LevelsAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.Pageof 19